Search | IOVS | ARVO Journals

Showing 1 – 20 of 36

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Disease activity (DA) monitoring in neovascular age-related macular degeneration (nAMD) with artificial intelligence (AI): a feasibility study

Pearse Andrew Keane; Jayashree Sahni; Zufar Mulyukov; Sandra Liakopoulos; Katja Hatz; Daniel Ting Shu Wei; Roberto Gallego Pinazo; Daniel Lorand

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2997 – F0267. doi:

ARVO Annual Meeting Abstract June 2022

A deep learning pipeline for the detection and quantification of drusen and reticular pseudodrusen on optical coherence tomography

Roy Schwartz; Hagar Khalid; Sandra Liakopoulos; Yanling Ouyang; Coen de Vente; Cristina González Gonzalo; Aaron Y Lee; Catherine A Egan; Clara Sánchez; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3856. doi:

ARVO Annual Meeting Abstract June 2022

Transformation of Subretinal Hyperreflective Material in Exudative Neovascular Age Related Macular Degeneration from Type 2 into Type 1 Appearance under anti-VEGF Therapy

Manuel Hermann; Anna Lentzsch; Robert Siggel; Ina Wegener; Christian Grefkes-Hermann; Uwe Rose; Hansjüergen T Agostini; Sandra Liakopoulos

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):344 – F0175. doi:

ARVO Annual Meeting Abstract June 2021

Optical Coherence Tomography Signs of Early Atrophy in Age-related Macular Degeneration: Inter-Reader Agreement

Steffen Schmitz-Valckenberg; Zhichao Wu; Maximilian Pfau; Barbara Blodi; Frank G Holz; Petrus Chang; Glenn J Jaffe; Sandra Liakopoulos; Srinivas R Sadda; Giovanni Staurenghi; Robyn H Guymer

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1936. doi:

Retina March 2020

Complement Activation Levels Are Related to Disease Stage in AMD

PDF

Thomas J. Heesterbeek; Yara T. E. Lechanteur; Laura Lorés-Motta; Tina Schick; Mohamed R. Daha; Lebriz Altay; Sandra Liakopoulos; Dzenita Smailhodzic; Anneke I. den Hollander; Carel B. Hoyng; Eiko K. de Jong; B. Jeroen Klevering
TAGS: complement activation, complement system proteins, choroidal neovascularization
Invest. Ophthalmol. Vis. Sci.. 2020; 61(3):18. doi: https://doi.org/10.1167/iovs.61.3.18

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Retreatment needs of patients with proliferative diabetic retinopathy treated with ranibizumab, laser or combination therapy

Andreas Stahl; Sandra Liakopoulos; Katrin Lorenz; Claudia Quiering; Laureen Sander; Georg Spital; Gabriele E Lang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1734. doi:

ARVO Annual Meeting Abstract July 2019

Influence of ranibizumab, laser photocoagulation or combination therapy on high-risk proliferative diabetic retinopathy

Katrin Lorenz; Gabriele E Lang; Andreas Stahl; Claudia Quiering; Laureen Sander; Georg Spital; Sandra Liakopoulos

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2789. doi:

ARVO Annual Meeting Abstract July 2019

Manually modified versus automated layer segmentation of Spectral-domain OCT Angiography images for detection of CNV in eyes with various chorioretinal diseases

Anna Maria Lentzsch; Christel Spital; Robert Siggel; Sandra Liakopoulos

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3001. doi:

ARVO Annual Meeting Abstract July 2018

Reporting of safety events across anti-VEGF indications and the Pharmacovigilance approach: Findings from the non-interventional OCEAN study

Focke Ziemssen; Jessica Voegeler; Georg Spital; Sandra Liakopoulos; Steffen Schmitz-Valckenberg; Thomas Bertelmann

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):215. doi:

ARVO Annual Meeting Abstract June 2017

Influence of OCT-examination during ranibizumab treatment of AMD patients in a real-life setting (OCEAN study)

Frederic Gunnemann; Jessica Voegeler; Steffen Schmitz-Valckenberg; Georg Spital; Sandra Liakopoulos; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):412. doi:

ARVO Annual Meeting Abstract June 2017

Dependency of BCVA and ranibizumab treatment frequency of DME patients in a real-life setting (OCEAN study)

Focke Ziemssen; Jessica Voegeler; Steffen Schmitz-Valckenberg; Georg Spital; Sandra Liakopoulos

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1904. doi:

ARVO Annual Meeting Abstract June 2017

Real-life effectiveness of Ranibizumab in RVO patients in a prospective, non-interventional trial over 12 months (OCEAN study)

Josep Callizo; Thomas Bertelmann; Jessica Voegeler; Steffen Schmitz-Valckenberg; Georg Spital; Nicolas Feltgen; Sandra Liakopoulos; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3674. doi:

ARVO Annual Meeting Abstract September 2016

Genetic and environmental risk factors for extramacular drusen

Xavier Subiras Rodriguez; Tina Schick; Aileen Berghold; Bernd Kirchhof; Anneke I den Hollander; Sascha Fauser; Sandra Liakopoulos

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2630. doi:

Retina November 2015

Phenotype Characteristics of Fellow Eyes in Patients With Early Onset of Neovascular Age-Related Macular Degeneration

PDF

Tina Schick; Lebriz Ersoy; Carel B. Hoyng; Bernd Kirchhof; Sandra Liakopoulos
TAGS: choroidal neovascularization, exudative age-related macular degeneration, eye, phenotype, drusen
Invest. Ophthalmol. Vis. Sci.. 2015; 56(12):7269-7273. doi: https://doi.org/10.1167/iovs.15-16989

ARVO Annual Meeting Abstract June 2015

Levels of Complement Activation Differ Between Stages of Age-related Macular Degeneration.

Yara Lechanteur; Tina Schick; Joannes Groenewoud; Lebriz Ersoy; Sandra Liakopoulos; Anneke I Den Hollander; Carel C B Hoyng; B. Jeroen Klevering

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):787. doi:

ARVO Annual Meeting Abstract June 2015

Impact of decentration of SDOCT volume scans on retinal thickness measurements in diabetic macula edema in a phase III multicenter randomized controlled trial (RELATION)

Daniel Michels; Tina Schick; Jessica Voegeler; Claudia Weiss; Georg Spital; Gabriele Elisabeth Lang; Sandra Liakopoulos; RELATION

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1528. doi:

Retina August 2014

Nongenetic Risk Factors for Neovascular Age-Related Macular Degeneration

PDF

Tina Ristau; Lebriz Ersoy; Moritz Hahn; Anneke I. den Hollander; Bernd Kirchhof; Sandra Liakopoulos; Sascha Fauser
TAGS: exudative age-related macular degeneration, risk factors, genetic risk, environmental factors
Invest. Ophthalmol. Vis. Sci.. 2014; 55(8):5228-5232. doi: https://doi.org/10.1167/iovs.14-14299

ARVO Annual Meeting Abstract April 2014

Segmentation Error versus Decentration Error of SDOCT Volume Scans in Eyes with Neovascular Age-related Macular Degeneration

Lisa A. Engel; Tina Ristau; Nils F Mokwa; Alexander Walsh; Bernd Kirchhof; Srinivas R Sadda; Sandra Liakopoulos

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3370. doi:

ARVO Annual Meeting Abstract June 2013

Double-Masked Trial Demonstrates Superiority Of Combined Ranibizumab Plus Laser Versus Laser In Patients With Diabetic Macular Edema With Or Without Proliferative Diabetic Retinopathy

Chris Lohmann; Jessica Voegeler; Sandra Liakopoulos; Peter Wiedemann; Georg Spital; Gabriele Lang; RELATION STUDY GROUP

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1239. doi:

ARVO Annual Meeting Abstract June 2013

Relevance of inner versus outer retinal thickness in diabetic macular edema in the RELATION study

Tina Ristau; Jessica Voegeler; Gabriele Lang; Sandra Liakopoulos; RELATION study group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2376. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Disease activity (DA) monitoring in neovascular age-related macular degeneration (nAMD) with artificial intelligence (AI): a feasibility study

A deep learning pipeline for the detection and quantification of drusen and reticular pseudodrusen on optical coherence tomography

Transformation of Subretinal Hyperreflective Material in Exudative Neovascular Age Related Macular Degeneration from Type 2 into Type 1 Appearance under anti-VEGF Therapy

Optical Coherence Tomography Signs of Early Atrophy in Age-related Macular Degeneration: Inter-Reader Agreement

Complement Activation Levels Are Related to Disease Stage in AMD

Retreatment needs of patients with proliferative diabetic retinopathy treated with ranibizumab, laser or combination therapy

Influence of ranibizumab, laser photocoagulation or combination therapy on high-risk proliferative diabetic retinopathy

Manually modified versus automated layer segmentation of Spectral-domain OCT Angiography images for detection of CNV in eyes with various chorioretinal diseases

Reporting of safety events across anti-VEGF indications and the Pharmacovigilance approach: Findings from the non-interventional OCEAN study

Influence of OCT-examination during ranibizumab treatment of AMD patients in a real-life setting (OCEAN study)

Dependency of BCVA and ranibizumab treatment frequency of DME patients in a real-life setting (OCEAN study)

Real-life effectiveness of Ranibizumab in RVO patients in a prospective, non-interventional trial over 12 months (OCEAN study)

Genetic and environmental risk factors for extramacular drusen

Phenotype Characteristics of Fellow Eyes in Patients With Early Onset of Neovascular Age-Related Macular Degeneration

Levels of Complement Activation Differ Between Stages of Age-related Macular Degeneration.

Impact of decentration of SDOCT volume scans on retinal thickness measurements in diabetic macula edema in a phase III multicenter randomized controlled trial (RELATION)

Nongenetic Risk Factors for Neovascular Age-Related Macular Degeneration

Segmentation Error versus Decentration Error of SDOCT Volume Scans in Eyes with Neovascular Age-related Macular Degeneration

Double-Masked Trial Demonstrates Superiority Of Combined Ranibizumab Plus Laser Versus Laser In Patients With Diabetic Macular Edema With Or Without Proliferative Diabetic Retinopathy

Relevance of inner versus outer retinal thickness in diabetic macular edema in the RELATION study

To View More...

You must be signed into an individual account to use this feature.